| 货号 | 规格 | 价格 | 上海 | 北京 | 珠海 | 重庆 | 武汉 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
V44183-5mg |
≥98% | ￥670.00 |
货期：3-5天 | - | - | - | - |
|
V44183-10mg |
≥98% | ￥1090.00 |
货期：3-5天 | - | - | - | - |
|
V44183-25mg |
≥98% | ￥2190.00 |
货期：3-5天 | - | - | - | - |
|
V44183-50mg |
≥98% | ￥3290.00 |
货期：3-5天 | - | - | - | - |
|
| 产品描述： | Gemigliptin (LC15-0444 ) tartrate hydrate is a selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin tartrate hydrate exhibits potent anti-glycation properties. Gemigliptin tartrate hydrate can be used for the research of advanced glycation end products (AGE)-related diabetic complications. | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 参考文献： | 1. Jung E, et al. Gemigliptin, a novel dipeptidyl peptidase-4 inhibitor, exhibits potent anti-glycation properties in vitro and in vivo. Eur J Pharmacol. 2014 Dec 5;744:98-102. 2. Kim SH, et al. Pharmacological profiles of gemigliptin (LC15-0444), a no 웿 Ů ñ 샮㡽䇘睜⪰ޏࠃ 䇩睜 |
||||||||||||||||||||
| 保存条件： | 2-8°C, 干燥 | ||||||||||||||||||||
| 配置溶液浓度参考： |
|
||||||||||||||||||||
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京